Membrane binding sites for plasma lipoproteins on endosomes from rat liver.
- 1 March 1989
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 86 (6) , 1880-1884
- https://doi.org/10.1073/pnas.86.6.1880
Abstract
Highly purified edosomal membranes from rat liver, enriched in receptors for a number of macromolecules taken up into hepatocytes via the coated pit/endosome/lysosome pathway [including the receptor for low density lipoproteins (LDL)], were used to characterize binding sites for lipoproteins containing apolipoprotein E. In endosomal membranes from livers of estradiol-treated rats, in which LDL receptors are induced manyfold, two high-affinity binding sites were found for two apolipoprotein E-rich lipoproteins: very low density .beta.-lipoproteins (.beta.-VLDL) from cholesterol-fed rabbits and rat chylomicron remnants. One of these sites, binding to which is inhibited by 30 mM EDTA, appears identical to the LDL receptor by ligand and immunoblotting and other characteristics. The other site, highly resistant to EDTA, does not bind LDL. Binding to the EDTA-resistant site, however, is readily inhibited by heparin (as is the LDL receptor) and also by antisera prepared against rat or bovine LDL receptor. The distribution of the EDTA-resistant site among early endosomes, late endosomes, and endosome-derived receptor-recycling membranes is similar to that of the LDL receptor and recycling receptors. The LDL receptor was present in endosomal membranes from livers of untreated rats at about 10% of the level found in membranes from estradiol-treated rats, but the EDTA-resistant site was barely detectable. No saturable binding of .beta.-VLDL that could not be inhibited by antisera to the LDL receptor could be detected in endosomal membranes from livers of either untreated or estradiol-treated rats. The EDTA-resistant site may be a modified form of the LDL receptor that recognizes apolipoprotein E but not the B apolipoprotein of LDL. Alternatively, it may be a distinct receptor sharing immunological determinants with the LDL receptor, specialized for the endocytosis of certain lipoproteins containing apolipoprotein E, including chylomicron remnants.This publication has 30 references indexed in Scilit:
- Metabolism of apolipoprotein B-100 in large very low density lipoproteins of blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits.Journal of Clinical Investigation, 1988
- Apolipoprotein E-binding proteins isolated from dog and human liver.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- Isolation and characterization of three endosomal fractions from the liver of estradiol-treated rats.Proceedings of the National Academy of Sciences, 1987
- The effect of ligand heterogeneity on the Scatchard plot. Particular relevance to lipoprotein binding analysis.Journal of Biological Chemistry, 1985
- Sorting and recycling of cell surface receptors and endocytosed ligands: The asialoglycoprotein and transferrin receptorsJournal of Cellular Biochemistry, 1983
- Isolation of rat hepatocyte plasma membranes. I. Presence of the three major domains.The Journal of cell biology, 1983
- Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor.Proceedings of the National Academy of Sciences, 1982
- Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat.Journal of Biological Chemistry, 1980
- Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol.Journal of Biological Chemistry, 1979
- Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol.Journal of Biological Chemistry, 1979